GAPDH and cancer: LLO91–99 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), GAPDH peptide 1–22 (GAPDH1–22) and GAPDH1–15 were used with success in DC vaccines for listeriosis as they induce strong cytotoxic-T-cell responses and DC activation [17–19], which are both useful properties for cancer vaccines.